TNF and psoriasis: The 4 classes of biologics are approved by the US Food and Drug Administration (FDA) to treat psoriasis, which contains inhibitors of tumor necrosis factor (TNF)-α, interleukin (IL)-17, interleukin (IL)-23 and interleukin (IL)-12/23 (6, 7).